In particular, rare ARHGAP10 variants are genetically and biologically associated with schizophrenia, and Rho-kinase may represent a promising drug target for schizophrenia treatment in patients with variants of ARHGAP10 and possibly other genes related to the RhoA/Rho-kinase pathway [99]. Here, RHOA is linked to schizophrenia.